Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts

BACKGROUND: Determining the somatic mutations of epidermal growth factor receptor (EGFR)-pathway networks is the key to effective treatment for non-small cell lung cancer (NSCLC) with tyrosine kinase inhibitors (TKIs).The somatic mutation frequencies and their association with gender, smoking histor...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Li, S, Li, L, Zhu, Y, Huang, C, Qin, Y, Liu, H, Ren-Heidenreich, L, Shi, B, Ren, H, Chu, X, Kang, J, Wang, W, Xu, J, Tang, K, Yang, H, Zheng, Y, He, J, Yu, G, Liang, N
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2014
Konular:
Epidemiology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4037826/
https://ncbi.nlm.nih.gov/pubmed/24743704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.210
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller